FCS

Research Conducted by Florida Cancer Specialists & Research Institute Featured at European Society of Medical Oncology 2023 Congress

Retrieved on: 
Friday, October 20, 2023

FORT MYERS, Fla., Oct. 20, 2023 /PRNewswire/ -- Research conducted by Florida Cancer Specialists & Research Institute, LLC (FCS) is featured this week among the latest advancements and findings in cancer care at the European Society of Medical Oncology (ESMO) Congress in Madrid, Spain. Five FCS physicians are the first authors and/or co-authors of 12 cancer research studies that will be shared at the global gathering of oncologists, researchers, patient advocates, pharmaceutical representatives and journalists. With more than 30,000 members from 168 countries worldwide, ESMO is the leading professional organization for medical oncology.

Key Points: 
  • FORT MYERS, Fla., Oct. 20, 2023 /PRNewswire/ -- Research conducted by Florida Cancer Specialists & Research Institute, LLC (FCS) is featured this week among the latest advancements and findings in cancer care at the European Society of Medical Oncology (ESMO) Congress in Madrid, Spain.
  • With more than 30,000 members from 168 countries worldwide, ESMO is the leading professional organization for medical oncology.
  • The ESMO Congress 2023 is a global stage for the exchange of potentially practice-changing data and multidisciplinary conversations that will spur transformative therapies against cancer.
  • All of the study abstracts will be published online in the ESMO Congress 2023 Abstract Book, a supplement to the official ESMO journal, Annals of Oncology.

Florida Cancer Specialists & Research Institute Leaders Share Expert Insights at Value-Based Cancer Care Summit

Retrieved on: 
Wednesday, October 18, 2023

FORT MYERS, Fla., Oct. 18, 2023 /PRNewswire/ -- Executive leaders of Florida Cancer Specialists & Research Institute (FCS) will serve on the faculty for the Association for Value-Based Cancer Care 2023 Summit & Educational Program in New York, NY on Oct. 18 - 20.

Key Points: 
  • FORT MYERS, Fla., Oct. 18, 2023 /PRNewswire/ -- Executive leaders of Florida Cancer Specialists & Research Institute (FCS) will serve on the faculty for the Association for Value-Based Cancer Care 2023 Summit & Educational Program in New York, NY on Oct. 18 - 20.
  • During the invitation-only forum, they will join leading physicians, policymakers, pharmacists and payers from across the country to share insights and best practice strategies that focus on clinical, cost and access issues designed to maximize value in cancer care.
  • Dr. Lucio Gordan added, "We remain steadfast in our commitment to ensuring that cancer patients receive optimal care at every step of their journey.
  • By sharing our experiences and perspectives, especially as it relates to emerging opportunities in in the field of real-world data research, we will continue to find meaningful solutions to advance the many facets of value-based cancer care."

Florida Cancer Specialists & Research Institute Optimizing Use of Anticancer Drugs to Improve Care for Patients with Blood Disorders

Retrieved on: 
Wednesday, October 18, 2023

FORT MYERS, Fla., Oct. 18, 2023 /PRNewswire/ -- A best practice clinical program developed by Florida Cancer Specialists & Research Institute, LLC (FCS) is ensuring that patients with certain blood disorders achieve maximum clinical benefits from the use of oral medications. Detailed findings of a recent study, conducted by the FCS Real-World Evidence department in partnership with Karyopharm Therapeutics, Inc., will be shared this month at the Leukemia Lymphoma and Myeloma Congress in New York City.

Key Points: 
  • FORT MYERS, Fla., Oct. 18, 2023 /PRNewswire/ -- A best practice clinical program developed by Florida Cancer Specialists & Research Institute, LLC (FCS) is ensuring that patients with certain blood disorders achieve maximum clinical benefits from the use of oral medications.
  • Co-authors include Lucio N. Gordan, MD , FCS President & Managing Physician, and FCS medical oncologists Matthew Fink, MD , David Wenk, MD and Shachar Peles, MD .
  • The Leukemia Lymphoma and Myeloma Congress is one of the most respected forums for industry-leading hematologic research and clinical case studies.
  • FCS physicians and clinicians will join Industry-leading experts to explore the controversial and complex world of blood cancer through debate, discussion and networking.

Florida Cancer Specialists & Research Institute Announces Bradley Monk, MD as Medical Director of Late-Phase Clinical Research Program

Retrieved on: 
Tuesday, October 10, 2023

FORT MYERS, Fla., Oct. 10, 2023 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to announce that Bradley Monk, MD will join the statewide practice as Medical Director of Late-Phase Research, effective January 1, 2024.

Key Points: 
  • FORT MYERS, Fla., Oct. 10, 2023 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to announce that Bradley Monk, MD will join the statewide practice as Medical Director of Late-Phase Research, effective January 1, 2024.
  • Bradley Monk, MD to join FCS as Medical Director of Late-Phase Clinical Research in January 2024.
  • Board-certified in gynecologic oncology and obstetrics and gynecology, Dr. Monk joins FCS with extensive experience in clinical research and the development of clinical research programs in community oncology settings.
  • "The research and innovation coming out of FCS is paving the way for the next generation of medical oncologists and hematologists.

Ionis shares significant business and pipeline progress at Innovation Day, highlighting strength of capabilities from research and technology through commercialization

Retrieved on: 
Wednesday, October 4, 2023

Presentations from Ionis leaders and external physicians will highlight Ionis' comprehensive integrated research, development, and commercialization capabilities, along with key pipeline and technology highlights.

Key Points: 
  • Presentations from Ionis leaders and external physicians will highlight Ionis' comprehensive integrated research, development, and commercialization capabilities, along with key pipeline and technology highlights.
  • "Our powerful and prolific research and development engine has discovered groundbreaking medicines for people with devastating diseases.
  • We have matched this engine with a talented commercial organization poised to deliver a steady flow of wholly owned medicines to patients.
  • The event will take place at the Westin New York Grand Central from 8:00 a.m. to 3:00 p.m. Eastern Time and will also be webcast.

Micro Fulfillment Centers: Transforming E-commerce Delivery and Projected to Reach $36 Billion Opportunity by 2030 - ResearchAndMarkets.com

Retrieved on: 
Monday, October 2, 2023

The Micro Fulfillment Center (MFC) market is rapidly growing and is expected to offer substantial opportunities in the coming years, with a cumulative opportunity worth $36 billion by 2030.

Key Points: 
  • The Micro Fulfillment Center (MFC) market is rapidly growing and is expected to offer substantial opportunities in the coming years, with a cumulative opportunity worth $36 billion by 2030.
  • Market Expansion: The Micro Fulfillment Market is projected to grow 2 times by 2025 and 12 times by 2030 compared to the current market size in 2022.
  • Contributions: MFC services are expected to contribute approximately $2 billion by 2030, highlighting the significance of this emerging market.
  • Delivery Options: Multiple delivery options such as home delivery, in-store pick-up, curb-side pickup, and locker delivery are expected to be available.

MFCs Poised for Explosive Growth: Revolutionizing E-commerce Fulfillment with a $5 Billion Revenue Forecast by 2030

Retrieved on: 
Tuesday, September 26, 2023

The Micro Fulfillment Center (MFC) market is rapidly growing and is expected to offer substantial opportunities in the coming years, with a cumulative opportunity worth $36 billion by 2030.

Key Points: 
  • The Micro Fulfillment Center (MFC) market is rapidly growing and is expected to offer substantial opportunities in the coming years, with a cumulative opportunity worth $36 billion by 2030.
  • Market Expansion: The Micro Fulfillment Market is projected to grow 2 times by 2025 and 12 times by 2030 compared to the current market size in 2022.
  • Contributions: MFC services are expected to contribute approximately $2 billion by 2030, highlighting the significance of this emerging market.
  • Market Revenue: The market is expected to generate more than $5 billion in revenue from Micro Fulfillment automation by 2030, primarily driven by Grocery Omnichannel and Pure-Play E-commerce/Q-commerce players.

Accton Announces 800G-Optimized Products that Provide Ethernet and VoQ Fabrics for AI/ML Workloads

Retrieved on: 
Tuesday, September 12, 2023

Accton Technology Corporation (Accton) (TWSE: 2345), a leading provider of networking and communications solutions, today announced a series of 800G-optimized products that can provide Ethernet-based fabric and Virtual Output Queue (VoQ) based fabric for AI/ML workloads.

Key Points: 
  • Accton Technology Corporation (Accton) (TWSE: 2345), a leading provider of networking and communications solutions, today announced a series of 800G-optimized products that can provide Ethernet-based fabric and Virtual Output Queue (VoQ) based fabric for AI/ML workloads.
  • AI networks require high-capacity systems in a flat architecture that can handle large amounts of data with low latency and high throughput.
  • To meet the demands of AI/ML workloads, either Ethernet-based fabrics or VoQ-based fabrics are being adopted to reduce job completion time.
  • Accton’s 51.2 Tbps Broadcom StrataXGS® Tomahawk® 5 series-based system with 64x800G or 128x400G ports provides a high-radix, deployment-friendly Ethernet-fabric.

Florida Cancer Specialists & Research Institute Welcomes Hematologist and Medical Oncologist Raphael Bosse, MD, PhD to Collier County

Retrieved on: 
Tuesday, September 12, 2023

FORT MYERS, Fla., Sept. 12, 2023 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to announce that Board-certified hematologist and medical oncologist Raphael Bosse, MD, PhD has joined the statewide practice.

Key Points: 
  • FORT MYERS, Fla., Sept. 12, 2023 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to announce that Board-certified hematologist and medical oncologist Raphael Bosse, MD, PhD has joined the statewide practice.
  • He is providing care to patients at the Naples-Goodlette location , 1100 Goodlette Road N., Naples, Florida 34102.
  • Dr. Bosse received his medical degree and doctorate in Molecular Cell Biology & Hematology from the University of Florida College of Medicine.
  • "We are delighted to welcome Dr. Bosse to our team of cancer experts in Collier County," said FCS Chief Executive Officer Nathan H. Walcker .

Panacea Healthcare Solutions to Exhibit at NAHRI RIS Symposium, Featuring Panel Discussion on Adding Clarity and Value to the CDM

Retrieved on: 
Friday, September 8, 2023

ST. PAUL, Minn., Sept. 8, 2023 /PRNewswire-PRWeb/ -- Panacea Healthcare Solutions, a leading provider of Financial and Revenue Integrity Solutions, including strategic pricing, price transparency, chargemaster, compliance, and revenue integrity software, education, and consulting services to healthcare providers across the full continuum of care, is excited to announce its participation as both an exhibitor and sponsor at the upcoming NAHRI Revenue Integrity Symposium (RIS) on September 18 and 19 in Charlotte, North Carolina. The symposium is a premier event for revenue integrity professionals to explore the latest trends, strategies, and best practices in the field.

Key Points: 
  • One of the highlights of the symposium will be a distinguished panel discussion titled "Adding Clarity and Value to the CDM," featuring notable industry experts.
  • The panel discussion will delve into the crucial topic of enhancing the charge description master (CDM) for improved clarity and value.
  • The upcoming NAHRI RIS Symposium provides a unique platform to explore best-practice strategies for enhancing the CDM's value and clarity.
  • For more information about Panacea Healthcare Solutions and its participation in the NAHRI RIS Symposium, please visit: https://www.panaceainc.com/chargeassist